Cytogenetic information is important in the diagnosis, classification, and prognostication of acute myeloid leukemia (AML). Data obtained from multicenter treatment trials are well published. In this study, we contribute cytogenetic data from a large series of 629 Chinese patients with de novo AML that were karyotyped in a single laboratory. A higher prevalence of acute promyelocytic leukemia was observed when compared with non-Chinese series. The difference was most prominent in the younger age group. Abnormalities at chromosomal region 11q23 and inv(16) seemed uncommon. These ethnic differences may indicate underlying genetic susceptibility to AML development and/or environmental differences. More comprehensive data on AML in the elder po...
Diagnostic karyotype provides the framework for risk-stratification schemes in acute myeloid leukemi...
Diagnostic karyotype provides the framework for risk-stratification schemes in acute myeloid leukemi...
Diagnostic karyotype provides the framework for risk-stratification schemes in acute myeloid leukemi...
The cytogenetic and molecular data is recognized as the most valuable prognostic factor in acute mye...
Abstract- Cytogenetics has now been well established as one of the most valuable prognostic factors ...
Cytogenetics has now been well established as one of the most valuable prognostic factors in acute m...
The karyotypes of 98 patients between the ages of 8 and 81 years with acute lymphoblastic leukemia (...
Cytogenetic studies with high-resolution banding were performed on specimens from 132 consecutive pa...
Cytogenetic studies with high-resolution banding were performed on specimens from 132 consecutive pa...
Cytogenetic studies with high-resolution banding were performed on specimens from 132 consecutive pa...
Cytogenetic studies with high-resolution banding were performed on specimens from 132 consecutive pa...
Few large demographic studies of acute myeloid leukemia (AML) are derived from population-based regi...
Mixed phenotype acute leukemia (MPAL) is a complex entity expressing both lymphoid and myeloid immun...
Diagnostic karyotype provides the framework for risk-stratification schemes in acute myeloid leukemi...
Diagnostic karyotype provides the framework for risk-stratification schemes in acute myeloid leukemi...
Diagnostic karyotype provides the framework for risk-stratification schemes in acute myeloid leukemi...
Diagnostic karyotype provides the framework for risk-stratification schemes in acute myeloid leukemi...
Diagnostic karyotype provides the framework for risk-stratification schemes in acute myeloid leukemi...
The cytogenetic and molecular data is recognized as the most valuable prognostic factor in acute mye...
Abstract- Cytogenetics has now been well established as one of the most valuable prognostic factors ...
Cytogenetics has now been well established as one of the most valuable prognostic factors in acute m...
The karyotypes of 98 patients between the ages of 8 and 81 years with acute lymphoblastic leukemia (...
Cytogenetic studies with high-resolution banding were performed on specimens from 132 consecutive pa...
Cytogenetic studies with high-resolution banding were performed on specimens from 132 consecutive pa...
Cytogenetic studies with high-resolution banding were performed on specimens from 132 consecutive pa...
Cytogenetic studies with high-resolution banding were performed on specimens from 132 consecutive pa...
Few large demographic studies of acute myeloid leukemia (AML) are derived from population-based regi...
Mixed phenotype acute leukemia (MPAL) is a complex entity expressing both lymphoid and myeloid immun...
Diagnostic karyotype provides the framework for risk-stratification schemes in acute myeloid leukemi...
Diagnostic karyotype provides the framework for risk-stratification schemes in acute myeloid leukemi...
Diagnostic karyotype provides the framework for risk-stratification schemes in acute myeloid leukemi...
Diagnostic karyotype provides the framework for risk-stratification schemes in acute myeloid leukemi...
Diagnostic karyotype provides the framework for risk-stratification schemes in acute myeloid leukemi...